Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 06, 2022
ICON plc has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax...
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
Tuesday, December 21, 2021
Ichor Life Sciences, a preclinical contract research organization offering services in discovery through pharmacology, has formally completed the acquisition of Woodland Biosciences, Inc. The in vivo services for the study of metabolic diseases and ...
read more
Wednesday, March 07, 2018
iBio announced the expansion of its CDMO capabilities and services to include the development and cGMP manufacturing of Fc fusion proteins for therapeutic pharmaceutical applications.
read more
iBio announced the activation of its new cGMP sterile fill-finish services operation via the signing of a supply agreement with a clinical-stage biopharmaceutical company.
read more
TraceLink announced that IBI Lorenzini has selected TraceLink's solutions to ensure compliance with global serialization regulations.
read more
IBC Life Sciences, an Informa business dedicated to providing rich conference content, valuable connections and business development opportunities, today opened the 11th Annual Single-Use Applications 2014 conference with the news that it will ...
read more
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
Wednesday, April 01, 2020
I-Mab announced a strategic partnership with Kalbe Genexine Biologics.
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Monday, September 18, 2017
PuraCap announced the FDA has completed a successful general inspection of its affiliated soft gelatin capsule manufacturing facility located in Wuhan, Hubei Province China.
read more
Monday, September 28, 2020
Humanigen announced a strategic collaboration with Thermo Fisher Scientific to expand the manufacturing capacity for lenzilumab, currently in a Phase 3 registration study in patients with COVID-19.
read more
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Tuesday, October 12, 2021
Humanigen announced it has entered into an arrangement with Clinigen to implement a Managed Access Program for lenzilumab (“LenzMAP™”).
read more
Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s anti-human GM-CSF monoclonal antibody.
read more